Clotiazepam
From Wikipedia, the free encyclopedia
|
Clotiazepam
|
|
| Systematic (IUPAC) name | |
| 2-(2-chlorophenyl)-9-ethyl-6-methyl- 8-thia-3,6-diazabicyclo[5.3.0]deca-2,9,11-trien-5-one | |
| Identifiers | |
| CAS number | |
| ATC code | N05 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C16H15ClN2OS |
| Mol. mass | 318.8 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | ? |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
Clotiazepam (marketed under brand name Trecalmo) is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Stage 2 NREM sleep is significantly increased by clotiazepam.[1]
Clotiazepam is not approved for sale in the United States or Canada.
[edit] References
[edit] External links
|
||||||||||||||||||||||||||

